scorecardresearch
Monday, September 22, 2025
TopicSerum Institute of India

Topic: Serum Institute of India

Serum Institute manufacturing 1st batch of Covovax Covid vaccine this week, says Poonawalla

SII CEO Poonawalla said the vaccine, developed by US company Novavax, has great potential to protect those below the age of 18 and trials are ongoing.

Covovax vaccine samples cleared by national drug lab, phase 3 trials could begin by July

Covovax, Novavax's Indian version, will be tested on 1,400 volunteers across 20 cities by Serum Institute, which has already begun production of the Covid vaccine.

Pune cell science centre could soon get Modi govt nod to test and approve Covid vaccines

If given a go-ahead, National Centre for Cell Science will be the 2nd centre after Central Drugs Laboratory, Kasauli, to test Covid-19 vaccines.

How setbacks at India’s Serum Institute have left the world short on Covid vaccines

SII's problems have become a key illustration of how the effort to inoculate developing world has failed, & a cautionary tale for becoming over-reliant on one manufacturer.

‘Same rules for everyone’: SII reiterates indemnity demand as govt negotiates with Pfizer

Modi government has so far stood firm on not offering indemnity to Covid vaccine makers. But vaccine shortage could force it reconsider as it negotiates with foreign companies.

Serum Institute seeks DCGI permission to manufacture Sputnik V vaccine

The SII has already told the government that it will be able to manufacture and supply 10 crore Covishield doses in June and is also manufacturing the Novavax vaccine.

Will be able to supply 10 crore Covishield doses in June –– Serum Institute tells Govt

In early May, SII had informed the Central govt that production of Covishield would be ramped up to 6.5 crore in June, 7 crore in July and 10 crore each in August and September.

SubscriberWrites: Modi govt must drop its hubris, accept mistakes and give a fresh shot at procuring vaccines

Since it was Modi who took the credit for India being a saviour to the world at international forums, the blame must also be his.

Vaccine alliance Gavi expects India to resume supplies soon, even if ‘in reduced quantities’

The vaccine alliance had, in March, braced for a delay in Covid-19 vaccine deliveries from India, after the second wave hit the country.

SII begins manufacturing, stockpiling 2nd Covid vaccine Covovax after Modi govt nod

SII has a tie-up with US' Novavax to manufacture and supply Covovax vaccine in India and in low- and middle-income countries as part of the COVAX vaccine alliance countries.

On Camera

1979 Mecca siege flashback—Saudi resorts to Pakistan to protect the Kingdom

Even though the Western media sometimes gives the impression that young Saudis overwhelmingly back Prince Salman’s efforts, some data suggest there is a deep pool of resentment.

Market regulator SEBI clears Adani Group of impropriety alleged by Hindenburg Research

SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.

60 yrs on, veterans recall lessons from 1965 India-Pakistan war. ‘Equipment alone doesn’t win battles’

A common thread runs through the memories of soldiers of the 1965 war—ingenuity, courage and camaraderie that withstood an apparently technologically superior foe.

India doesn’t give walkovers to Pakistan in war. Here’s why it shouldn’t do it in cricket either

Many really smart people now share the position that playing cricket with Pakistan is politically, strategically and morally wrong. It is just a poor appreciation of competitive sport.